About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Indian Neem Tree Offers Hope For Cancer Patients

by VR Sreeraman on February 15, 2013 at 7:23 PM
Font : A-A+

 Indian Neem Tree Offers Hope For Cancer Patients

Neem tree, which is widely used in traditional Indian medicine to treat various ailments, could also help kill cancer cells, according to scientists.

Cancer cells typically avoid death by hijacking molecular chaperones that guide and protect the proteins that ensure normal cellular function and then tricking them into helping mutated versions of those proteins stay alive, said Dr. Ahmed Chadli, a researcher in the Molecular Chaperone Program at the GRU Cancer Center and senior author of the study.

Advertisement

Drug development has focused on the chaperone Hsp90 (heat shock protein 90) because it plays a key role in assisting mutated proteins, making it an attractive cancer drug target.

However, the clinical efficacy of Hsp90 inhibitors has been disappointing. Most current small molecules targeting Hsp90 have inadvertently resulted in the expression of proteins that protect cancer cells from programmed cell death and compromise the Hsp90 inhibitors in the clinic.
Advertisement

In this study, however, Chaitanya Patwardhan, a graduate student in Dr. Chadli's lab, found that gedunin, a compound extracted from the Indian neem tree (Azadirachta indica), attacks a co-chaperone, or helper protein, of Hsp90 called p23.

"This compound binds directly to p23, leading to inactivation of the Hsp90 machine-without production of anti-apoptotic proteins-thus killing cancer cells," explained Dr. Chadli.

"The idea here is that this will open a door for new ways of targeting Hsp90 by targeting its helper proteins, which may be used in combination with established Hsp90 inhibitors that are ongoing clinical trials. In the future, this research could have applications in drug development for hormone-dependent cancers, including breast, prostate and endometrial cancers," he added.

Dr. Samir N. Khleif, Director of the GRU Cancer Center, said "one of the major areas of scientific emphasis of the GRU Cancer Center is to develop therapeutic approaches to cancer targeting specific molecules within the cancer cell, including chaperones."

"This finding is an important piece of the puzzle, bringing us closer to our goal of helping patients with cancer," he added.

The study has been named the Journal of Biological Chemistry's Paper of the Week.

Source: ANI
Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Indian Neem Tree Offers Hope For Cancer Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests